Literature DB >> 24631392

mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests.

Mira Lainiola1, Chiara Procaccini1, Anni-Maija Linden2.   

Abstract

Polymorphisms in the metabotropic glutamate receptor 3 (mGluR3) encoding gene GRM3 have been linked to schizophrenia and cognitive performance in humans. Our aim was to analyze the role of mGluR3 in basal working memory and attentional processes, and also when these functions were distracted by the psychotomimetic N-methyl-d-aspartate (NMDA) receptor antagonist dizocilpine (MK-801). mGluR3 knockout (KO) mice were used. Spontaneous alternation in a T-maze test was significantly reduced in mGluR3-KO mice compared to wildtype (WT) mice, particularly after a low dose of MK-801 (0.03 mg/kg, i.p., 30 min). In a Y-maze novelty discrimination test, the locomotor stimulatory effect of MK-801 (0.1mg/kg) was enhanced in mGluR3-KO mice. Interestingly, mGluR3-KO mice showed the significantly reduced alternation in the spontaneous alternation T-maze test and the significantly enhanced sensitivity to MK-801 in the Y-maze test only when forced to enter the right arm first, not when the forced arm was on the left. A side-biased response was also found in a rewarded alternation T-maze test, where mGluR3-KO mice made significantly more incorrect visits to the left arm than the right arm after a 25-s delay. No genotype difference was found in the novelty discrimination in the Y-maze test, rewarded alternation with a 5-s delay, preference for left or right when free to enter either arm or in MK-801-induced circling. Our findings indicate cognitive disturbance and left-right asymmetry in certain behavioral responses of mGluR3-KO mice. This novel observation warrants further elucidation, and should also be considered in other studies of mGluR3 in brain functions.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dizocilpine; Left-right asymmetry; Mouse; Side bias; Working memory; mGlu3 receptor

Mesh:

Substances:

Year:  2014        PMID: 24631392     DOI: 10.1016/j.bbr.2014.03.008

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  23 in total

Review 1.  Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?

Authors:  Meng-Lin Li; Xi-Quan Hu; Feng Li; Wen-Jun Gao
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-24       Impact factor: 5.067

2.  Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction.

Authors:  Adam G Walker; Cody J Wenthur; Zixiu Xiang; Jerri M Rook; Kyle A Emmitte; Colleen M Niswender; Craig W Lindsley; P Jeffrey Conn
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

Review 3.  Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors.

Authors:  Branden J Stansley; P Jeffrey Conn
Journal:  Trends Pharmacol Sci       Date:  2019-02-26       Impact factor: 14.819

4.  Behavioral Phenotyping for Autism Spectrum Disorders in Mice.

Authors:  Yu-Chi Chang; Toby B Cole; Lucio G Costa
Journal:  Curr Protoc Toxicol       Date:  2017-05-02

Review 5.  Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics.

Authors:  Adam G Walker; P Jeffrey Conn
Journal:  Curr Opin Pharmacol       Date:  2014-11-27       Impact factor: 5.547

6.  Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndrome.

Authors:  Sheryl Anne D Vermudez; Aditi Buch; Kelly Weiss; Rocco G Gogliotti; Colleen M Niswender
Journal:  Neuropharmacology       Date:  2022-03-03       Impact factor: 5.250

7.  An aqueous extract of Syzygium cumini protects against kainate-induced status epilepticus and amnesia: evidence for antioxidant and anti-inflammatory intervention.

Authors:  Antoine Kavaye Kandeda; Saleh Nodeina; Symphorien Talom Mabou
Journal:  Metab Brain Dis       Date:  2022-08-02       Impact factor: 3.655

8.  Nicotine pretreatment alleviates MK-801-induced behavioral and cognitive deficits in mice by regulating Pdlim5/CRTC1 in the PFC.

Authors:  Qian Wang; Meng-Wei Wang; Yan-Yun Sun; Xiao-Yan Hu; Pan-Pan Geng; Hui Shu; Xiao-Na Wang; Hao Wang; Jun-Fang Zhang; Hong-Qiang Cheng; Wei Wang; Xin-Chun Jin
Journal:  Acta Pharmacol Sin       Date:  2022-08-29       Impact factor: 7.169

9.  Detrimental Effects of Restricted Cage Size on Reproductive Performance, Exploration Ability, and Anxiety but Not Working Memory of Kunming Mice.

Authors:  Wenzhen An; Ying Zhang; Aibao Zhou; Yuzheng Hu
Journal:  Front Behav Neurosci       Date:  2021-05-26       Impact factor: 3.558

10.  Activating mGlu3 Metabotropic Glutamate Receptors Rescues Schizophrenia-like Cognitive Deficits Through Metaplastic Adaptations Within the Hippocampus.

Authors:  Shalini Dogra; Branden J Stansley; Zixiu Xiang; Weilun Qian; Rocco G Gogliotti; Ferdinando Nicoletti; Craig W Lindsley; Colleen M Niswender; Max E Joffe; P Jeffrey Conn
Journal:  Biol Psychiatry       Date:  2021-03-06       Impact factor: 12.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.